Bio-Rad Laboratories, Inc.
BIO- Exchange
- NYSE
- Industry
- Laboratory Analytical Instruments
- SEC CIK
- 0000012208
No open-market purchases or sales by Bio-Rad Laboratories, Inc. insiders were filed in the last 90 days; 400 institutions reported holding it in 13F filings for Q2 2026, worth $5.70B in total; no superinvestor holds it.
Other share classesBIO.B
Q3 2024 vs. Q2 2024
How the institutions holding Bio-Rad Laboratories, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 441 | 3 | 440 | +2 |
| Shares | 19.8M | 1.55M | 19.4M | +1.17M (+6.4%) |
| Value | $5.41B | $424.1M | $6.50B | +$1.52B (+30.5%) |
3 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (70)
Institutions that held Bio-Rad Laboratories, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
Sold out (68)
Institutions that held Bio-Rad Laboratories, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
Not filed for Q3 2024 yet (3)
Institutions that held Bio-Rad Laboratories, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 1,550,569 | $423.5M |
| Fjarde AP-fonden (The Fourth Swedish National Pensionfund) | 2,380 | $650.0K |
| Benjamin F. Edwards & Company, Inc. | 50 | $14.0K |